Akebia Therapeutics
AKBA
$1.32
Share price
-1.47%
Change (1 day)
45.08%
Change (1 year)
Categories
Earnings for Akebia Therapeutics (AKBA)
Earnings in 2023 (TTM): -$51.27 M
According to Akebia Therapeutics's latest financial reports the company's current earnings (TTM) are -$51.27 M. In 2022 the company made an earning of -$94.62 M an increase over its 2021 earnings that were of -$0.29 B.The earnings displayed on this page is the company's Pretax Income.
Earnings history for Akebia Therapeutics from 2013 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$51.27 M | -45.82% |
| 2022 | -$94.62 M | -66.55% |
| 2021 | -$0.29 B | -26.24% |
| 2020 | -$0.39 B | 33.94% |
| 2019 | -$0.29 B | 66.52% |
| 2018 | -$0.18 B | 123.53% |
| 2017 | -$76.92 M | -43.34% |
| 2016 | -$0.14 B | 123.58% |
| 2015 | -$60.72 M | 63.95% |
| 2014 | -$37.04 M | 181.24% |
| 2013 | -$13.17 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $16.97 B | -33,207.05% | 🇺🇸 USA |
 Novartis NVS | $9.82 B | -19,269.40% | 🇨🇭 Switzerland |
 Amgen AMGN | $7.85 B | -15,422.64% | 🇺🇸 USA |
 Nektar Therapeutics
NKTR | -$0.28 B | 438.89% | 🇺🇸 USA |